Dr Magda F Louka, DO | |
1050 Clove Road, Staten Island, NY 10301 | |
(718) 816-6440 | |
(718) 816-3611 |
Full Name | Dr Magda F Louka |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 1050 Clove Road, Staten Island, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013238591 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 368788 (New York) | Primary |
Entity Name | Practice Associates Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
A drug information interface system developed by two University of Alberta researchers has been shown to help in dealing with visual and motor impairments, which can make sorting, holding and indentifying pills a challenge as we age.
Valerie Stull was 12 when she ate her first insect. "I was on a trip with my parents in Central America and we were served fried ants," she says. "I remember being so grossed out initially, but when I put the ant in my mouth, I was really surprised because it tasted like food - and it was good!"
According to new research, women are at a highest risk of breast cancer, more than two decades after having given birth. This finding comes along with another in a separate study that reveals that breast cancers occurring after childbirth are more likely to spread compared to breast cancers in women who never had children.
Among a group of patients with severe obesity who underwent bariatric surgery, a large percentage experienced improvement in pain, physical function, and walking capacity over 3 years, according to a study appearing in the April 5 issue of JAMA.
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
› Verified 9 days ago
Entity Name | Barnabas Health Medical Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951 |
News Archive
A drug information interface system developed by two University of Alberta researchers has been shown to help in dealing with visual and motor impairments, which can make sorting, holding and indentifying pills a challenge as we age.
Valerie Stull was 12 when she ate her first insect. "I was on a trip with my parents in Central America and we were served fried ants," she says. "I remember being so grossed out initially, but when I put the ant in my mouth, I was really surprised because it tasted like food - and it was good!"
According to new research, women are at a highest risk of breast cancer, more than two decades after having given birth. This finding comes along with another in a separate study that reveals that breast cancers occurring after childbirth are more likely to spread compared to breast cancers in women who never had children.
Among a group of patients with severe obesity who underwent bariatric surgery, a large percentage experienced improvement in pain, physical function, and walking capacity over 3 years, according to a study appearing in the April 5 issue of JAMA.
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Magda F Louka, DO 55 Water Street, 2nd Floor Cred Dept, New York, NY 10041 Ph: (646) 680-2888 | Dr Magda F Louka, DO 1050 Clove Road, Staten Island, NY 10301 Ph: (718) 816-6440 |
News Archive
A drug information interface system developed by two University of Alberta researchers has been shown to help in dealing with visual and motor impairments, which can make sorting, holding and indentifying pills a challenge as we age.
Valerie Stull was 12 when she ate her first insect. "I was on a trip with my parents in Central America and we were served fried ants," she says. "I remember being so grossed out initially, but when I put the ant in my mouth, I was really surprised because it tasted like food - and it was good!"
According to new research, women are at a highest risk of breast cancer, more than two decades after having given birth. This finding comes along with another in a separate study that reveals that breast cancers occurring after childbirth are more likely to spread compared to breast cancers in women who never had children.
Among a group of patients with severe obesity who underwent bariatric surgery, a large percentage experienced improvement in pain, physical function, and walking capacity over 3 years, according to a study appearing in the April 5 issue of JAMA.
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
› Verified 9 days ago
Dr. Alvin Man-hao Ho, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Tyrellan Ave, Staten Island, NY 10309 Phone: 929-292-3600 Fax: 929-292-3601 | |
Dr. Raja S Bhatia, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2334 Richmond Rd, Staten Island, NY 10306 Phone: 718-979-4948 Fax: 718-650-0084 | |
Tamara Anna Marie Saukin, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1920 Richmond Road, Staten Island, NY 10306 Phone: 718-351-5557 Fax: 718-351-5559 | |
Dr. Pamela Diane L. Escobar, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1441 South Ave Ste 701, Staten Island, NY 10314 Phone: 718-226-6461 | |
Dr. David Hoi Kim, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2079 Forest Ave, Staten Island, NY 10303 Phone: 718-815-6560 | |
Dr. Michael J Carpiniello, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 81 Seymour Ave, Staten Island, NY 10302 Phone: 718-815-1444 |